Cell Therapy · Regenerative Medicine
Regenerative medicine research.
Regenerative-mechanism preclinical research at ExoBioCorp covers MSC paracrine studies, EV-mediated repair models, mitochondrial transfer research, and tissue-scaffold seeding work. All materials are RUO and characterized to published criteria.
Research applications we supply
- MSC paracrine and conditioned-media studies
- MSC-EV cargo profiling and source-pharmacology comparisons
- Mitochondrial transfer in MSC-recipient cell co-culture
- Tissue scaffold seeding and re-epithelialization research
- Wound healing in-vitro and in-animal model assays
- Tri-lineage differentiation method development (osteogenic / adipogenic / chondrogenic)
Products typically supplied
- CytoCord™ UCT-NNC — Wharton's jelly source MSC population
- ExCyte™ extracellular vesicles — characterized MSC and UCB-derived EVs
- Nexa-HBMMSC-1M — bone marrow MSC for comparative-source studies
- Nexa-ASCS variants — adipose-derived MSC populations
- Nexa-HPL-SER — human platelet lysate for MSC expansion
Add-on characterization for regen-med research
- Mitochondrial membrane potential per lot
- Mitochondrial mass per lot
- ATP content per cell
- Tri-lineage differentiation potential demonstration
- Tetraspanin profile beyond minimum CD9/CD63/CD81 panel for EV preparations